The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate

NCT00841685 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-01-05

No results posted yet for this study

Summary

Implantation of fiducial markers in the prostate and daily check of the positioning during radiotherapy based on the implanted fiducial markers

Conditions

Interventions

DEVICE

Goldlock

Insertion of Goldlock marker

DEVICE

Visicoil smallest size

Insertion of Visicoil, smallest size, marker

DEVICE

Visicoil larger size

Insertion of Visicoil, larger size, marker

DEVICE

Bard goldmarker smallest size

Insertion of Bard goldmarker, smallest size

DEVICE

Bard goldmarker larger size

Insertion of Bard goldmarker, larger size

Sponsors & Collaborators

  • IBA, Germany

    collaborator UNKNOWN
  • Hospimed, Netherland

    collaborator UNKNOWN
  • Bard Ltd

    collaborator INDUSTRY
  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Gert De Meerleer, MD, PhD · University Hospital, Ghent

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-05-01
Completion
2012-05-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00841685 on ClinicalTrials.gov